Showing results (1481-1490 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA|April 13, 1999
Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life SupportI G Stiell, G A Wells, B J Field, et al.
Journal of Molecular and Cellular Cardiology|August 21, 2007
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat heartsWangde Dai, Loren J Field, Michael Rubart, et al.
Research in Developmental Disabilities|September 30, 2022
Agreement between parents' and clinical researchers' ratings of behavioral problems in children with fragile X syndrome and chromosome 15 imprinting disordersMarta Arpone, Lesley Bretherton, David J Amor, et al.
Antiviral Chemistry & Chemotherapy|October 30, 2003
ME-609: a treatment for recurrent herpes simplex virus infectionsJohan G Harmenberg, Aftab R Awan, Stefan Alenius, et al.
Brain, Behavior, and Immunity|October 17, 2017
Maternal depressive symptoms linked to reduced fecal Immunoglobulin A concentrations in infantsLiane J Kang, Petya T Koleva, Catherine J Field, et al.
Journal of Medicinal Chemistry|November 2, 2018
Neolymphostin A Is a Covalent Phosphoinositide 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Dual Inhibitor That Employs an Unusual Electrophilic Vinylogous EsterGabriel Castro-Falcón, Grant S Seiler, Özlem Demir, et al.
JAMA Pediatrics|February 21, 2018
Roles of Birth Mode and Infant Gut Microbiota in Intergenerational Transmission of Overweight and Obesity From Mother to OffspringHein M Tun, Sarah L Bridgman, Radha Chari, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 20, 2014
Experiences with maternal and perinatal death reviews in the UK--the MBRRACE-UK programmeJ J Kurinczuk, E S Draper, D J Field, et al.
Microbes and Infection|May 29, 2016
High fecal IgA is associated with reduced Clostridium difficile colonization in infantsSarah L Bridgman, Tedd Konya, Meghan B Azad, et al.
Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
Pageof 161